We are a forward-thinking technology company providing a novel life sciences platform for reliable and accurate detection of key changes in molecular structure that affect the critical quality attributes governing the safety, efficacy, and stability of biomolecules and their raw materials. Our powerful new analytical technique, Microfluidic Modulation Spectroscopy (MMS), provides in-depth structural information in a single automated analysis.
See Change through Microfluidic Modulation Spectroscopy
Our mission is to deploy the power of novel analytical tools in life science research and biopharmaceutical drug development, tackling previously unsolvable problems in structural biology.
The Aurora and Apollo directly measure protein secondary structure, making each a powerful tool for monitoring and understanding the mechanisms of protein stability and aggregation.
Protein quantitation is critically important in biopharmaceutical research and development labs in applications ranging from enzymatic studies to providing data for biopharmaceutical lot release.
Microfluidic Modulation Spectroscopy provides highly precise measurements of key secondary structure features, allowing new insights into even the smallest changes difficult to detect with existing technologies.
The Aurora and Apollo directly measure protein secondary structure, making it a powerful tool for monitoring and understanding the mechanisms of protein stability and aggregation.
Determining protein similarity for biologics is more challenging, compared to small molecules, due to their larger size and structural complexity. With the Aurora and Apollo systems, users can differentiate even the smallest of differences in structure and therefore confirm structural similarity with a high degree of precision.